LEF-1 – RMab

SKU: 7ac5f2815cb7 Categories: , , ,

IHC of LEF-1 on a FFPE Testicular Carcinoma Tissue

Specification Sheets
Safety Data Sheet


Intended Use For In Vitro Diagnostic Use
Summary and Explanation

Lymphoid enhancer-binding factor 1 (LEF1) is a protein that in humans is encoded by the LEF1 gene with a 48-kD nuclear protein that is expressed in pre-B and T cells. LEF1 coupling with β-catenin, functions as a key nuclear mediator of WNT/β-catenin signaling, which regulates cell proliferation and survival. LEF1 has an important role in lymphopoiesis, and is normally expressed in T and pro-B cells but not mature B cells. LEF1-mediated canonical Wnt signaling is required for morphogenesis of these skin appendages during embryogenesis. In normal lymphoid tissues, LEF-1 is nuclear localized and observed predominantly in T cells of the paracortical regions; staining was undetected in B cells.

LEF1 is highly overexpressed and associated with disease progression and poor prognosis in B-cell chronic lymphocytic leukemia. Strong nuclear expression of LEF1 has been observed in majority of chronic lymphocytic leukemia/small lymphocytic lymphoma cases and LEF1 is not detected in other small B cell lymphomas. Gene expression profiling revealed overexpression of LEF-1 in chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). LEF-1 immunostaining has been detected in all neoplastic cells of CLL/SLL cases. LEF-1 was identified in 50% of high grade follicular lymphoma and 38% of diffuse large B-cell lymphoma, but not in mantle cell lymphoma or marginal zone lymphoma. Recently, high LEF-1 was demonstrated as a favorable prognostic marker in cytogenetically normal acute myeloid leukemia. Due to its high sensitivity, LEF-1 has been proposed to be a suitable immunohistochemical marker for diagnosis and differential diagnosis for CLL/SLL.

Alternately spliced isoforms may play additional roles in regulating cell growth in colon carcinoma, and nuclear LEF-1 immunostaining was detected in 36% of adenocarcinoma brain metastases.

Antibody Type Rabbit Monoclonal Clone EP310
Isotype IgG Reactivity Paraffin, Frozen
Localization Nuclear Control Breast, Tonsil, Breast Carcinoma, Small Lymphocytic Lymphoma
Presentation LEF1 is a rabbit monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.
Catalog No. Antibody Type Dilution Volume/QTY
BSB 3377 Prediluted Ready-To-Use 3.0 ml
BSB 3378 Prediluted Ready-To-Use 7.0 ml
BSB 3379 Prediluted Ready-To-Use 15.0 ml
BSB 3380 Concentrated 1:50-1:200 0.1 ml
BSB 3381 Concentrated 1:50-1:200 0.5 ml
BSB 3382 Concentrated 1:50-1:200 1.0 ml
BSB 3383 Control Slides 5
Note: For concentrated antibodies, please centrifuge prior to use to ensure recovery of all product.

Related products

Skip to content